BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24942831)

  • 21. Creutzfeldt-Jakob disease in a patient with a lyophilized dura mater graft.
    Liscić RM; Brinar V; Miklić P; Barsić B; Himbele J
    Acta Med Croatica; 1999; 53(2):93-6. PubMed ID: 10705627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creutzfeldt-Jakob disease in patients who received a cadaveric dura mater graft--Spain, 1985-1992.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Jul; 42(28):560-3. PubMed ID: 8326950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes.
    Yamada M; Noguchi-Shinohara M; Hamaguchi T; Nozaki I; Kitamoto T; Sato T; Nakamura Y; Mizusawa H
    Neuropathology; 2009 Oct; 29(5):609-18. PubMed ID: 19659940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human dura mater and Creutzfeldt-Jakob disease.
    Muñoz Guerra MF
    J Oral Maxillofac Surg; 2001 May; 59(5):595. PubMed ID: 11326393
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune response in hosts with cadaveric dural grafts. Report of two cases.
    Alleyne CH; Barrow DL
    J Neurosurg; 1994 Oct; 81(4):610-3. PubMed ID: 7931597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease latency in Creutzfeldt-Jakob disease via dural grafting: a case report.
    Lang CJ; Heckmann JG; Querner V; Neundörfer B; Kornhuber J; Buchfelder M; Kretzschmar HA
    Eur J Epidemiol; 2001; 17(11):1013-4. PubMed ID: 12380713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probable Creutzfeldt-Jakob disease after a cadaveric dural graft.
    Lang CJ; Schüler P; Engelhardt A; Spring A; Brown P
    Eur J Epidemiol; 1995 Feb; 11(1):79-81. PubMed ID: 7489777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dura mater graft-associated Creutzfeldt-Jakob disease: the first case in Korea.
    Kim HL; Do JY; Cho HJ; Jeon YC; Park SJ; Ma HI; Song JH; Lee Y; Choi H; Choi KC; Kim YS; Zerr I; Kallenberg K; Kim YJ
    J Korean Med Sci; 2011 Nov; 26(11):1515-7. PubMed ID: 22065911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iatrogenic Creutzfeldt-Jakob disease subsequent to dural graft: persisting risk after 1987.
    Boutoleau C; Guillon B; Martinez F; Vercelletto M; Faure A; Fève JR
    Eur J Neurol; 2003 Sep; 10(5):521-3. PubMed ID: 12940833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of Creutzfeldt-Jakob disease associated with a dura mater graft in the United States.
    Blossom DB; Maddox RA; Beavers SF; Church KA; Thoroughman DA; Schonberger LB; Belay ED
    Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1396-7. PubMed ID: 17994521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK.
    Heath CA; Barker RA; Esmonde TF; Harvey P; Roberts R; Trend P; Head MW; Smith C; Bell JE; Ironside JW; Will RG; Knight RS
    J Neurol Neurosurg Psychiatry; 2006 Jul; 77(7):880-2. PubMed ID: 16627534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Creutzfeldt-Jakob disease after an embolization of intercostal arteries with cadaveric dura mater suggesting a systemic transmission of the prion agent.
    Defebvre L; Destée A; Caron J; Ruchoux MM; Wurtz A; Remy J
    Neurology; 1997 May; 48(5):1470-1. PubMed ID: 9153501
    [No Abstract]   [Full Text] [Related]  

  • 33. Dura mater graft-associated Creutzfeldt-Jakob disease with 30-year incubation period.
    Shijo M; Honda H; Koyama S; Ishitsuka K; Maeda K; Kuroda J; Tanii M; Kitazono T; Iwaki T
    Neuropathology; 2017 Jun; 37(3):275-281. PubMed ID: 27925304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts--Japan, 1979-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Dec; 52(48):1179-81. PubMed ID: 14654766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creutzfeldt-Jakob disease after extracranial dura mater embolization for a nasopharyngeal angiofibroma.
    Antoine JC; Michel D; Bertholon P; Mosnier JF; Laplanche JL; Beaudry P; Hauw JJ; Veyret C
    Neurology; 1997 May; 48(5):1451-3. PubMed ID: 9153491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foramen magnum decompression with removal of the outer layer of the dura as treatment for syringomyelia occurring with Chiari I malformation.
    Isu T; Sasaki H; Takamura H; Kobayashi N
    Neurosurgery; 1993 Nov; 33(5):845-9; discussion 849-50. PubMed ID: 8264881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Creutzfeldt-Jakob disease transmitted by cadaveric dural graft: a case report].
    Takayama S; Hatsuda N; Matsumura K; Nakasu S; Handa J
    No Shinkei Geka; 1993 Feb; 21(2):167-70. PubMed ID: 8459905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan.
    Hoshi K; Yoshino H; Urata J; Nakamura Y; Yanagawa H; Sato T
    Neurology; 2000 Sep; 55(5):718-21. PubMed ID: 10980745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human--and porcine--dura mater linked to iatrogenic CJD.
    Smith M
    Tex Dent J; 2006 May; 123(5):449. PubMed ID: 16967693
    [No Abstract]   [Full Text] [Related]  

  • 40. Pediatric Creutzfeldt-Jakob disease: probable transmission by a dural graft.
    Martínez-Lage JF; Sola J; Poza M; Esteban JA
    Childs Nerv Syst; 1993 Jul; 9(4):239-42. PubMed ID: 8402707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.